Journal of Health Politics Policy and Law

Papers
(The TQCC of Journal of Health Politics Policy and Law is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
The Unequal Pandemic: COVID-19 and Health Inequalities25
Scripting Death: Stories of Assisted Dying in America24
Section 1115 Substance Use Disorder Waivers: Opportunities and Limitations23
The Impacts of Politicization on Public Health Workers: The COVID-19 Pandemic in Oregon and Montana17
The Line between Medicaid and Marketplace: Coverage Effects from Wisconsin's Partial Expansion17
The Politics of the Gender Gap in COVID-19: Partisanship, Health Behavior, and Policy Preferences in the United States14
Same as It Ever Was? Persistence and Transformation in US Health Care Policy14
MAHA Won't Make Americans Healthy Again: The Politicization of U.S. Federal Health Agencies During the Second Trump Administration14
Entrenching Inequity, Eroding Democracy: State Preemption of Local Housing Policy13
EU Economic Governance as a Supranational Determinant of Health Inequalities in the Eurozone13
Public Health Under Attack: Continuity, Discontinuity, and History13
Why Some Nonelderly Adult Medicaid Enrollees Appear Ineligible Based on Their Annual Income13
The Limits to Food and Beverage Industry Influence over Fiscal and Regulatory Policy in Latin America12
Assessing US Pharmaceutical Policy and Pricing Reform Legislation in Light of European Price and Cost Control Strategies12
Authoritarian Regime Legitimacy and Health Care Provision: Survey Evidence from Contemporary China12
Marketing Opioids to Veterans and Older Adults: A Content Analysis of Internal Industry Documents Released from State of Oklahoma v. Purdue Pharma LP, et al.11
State Courts, State Legislatures, and Setting Abortion Policy11
Medicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical Benefits11
Ultimate Price: The Value We Place on Life11
Implementing Primary Care Reform in France: Bargaining, Policy Adaptation, and the Maisons de Santé Pluriprofessionnelles10
Medicaid's Political Development since 1965: How a Fragmented and Unequal Program Has Expanded10
Medicare for All—Running Down a Dream10
Using New Techniques to Examine the Past: A Computational Assessment of the First 50 Years of the Journal of Health Politics, Policy and Law10
The EU as a Political Determinant of Global Health: The Case of Research and Development Incentives for Orphan Medicines and Biotechnology9
Hospital Consolidation Across Geographic Markets: Insights from Market Participants on Mechanisms for Price Increases8
State Efforts to Regulate Provider Networks and Directories: Lessons for the Future8
The Evolution of Long-Term Care and Health Policy in the United States8
Does Policy Uncertainty Boost Vaccine Hesitancy? Political Controversy, the FDA, and COVID-19 Vaccine Hesitancy in Fall 20208
Grow and Hide: The History of America's Health Care State.7
Building Power for Health: The Grassroots Politics of Sustaining and Strengthening Medicaid7
Market Failure, State Failure: The Political Economy of Supply Chain Strengthening to Ensure Equitable Access to Vaccines and Medicines in Low- and Middle-Income Countries7
What the Evolution of 1332 Waivers Tells Us about Their Innovative Potential7
International Reference Pricing in the Context of US Drug Policy7
Vaccine Nationalism: How China's State Media Misinform about Western Vaccines and Highlight the Successes of Chinese Vaccines to Different Audiences7
Introduction: The Politics of Abortion 50 Years afterRoe6
Variation in Public Support for Government Action on Unexpected Medical Bills6
Science and Public Health in the Trump Era: The Dismantling of Evidence and Institutions and Proposals for Reconstruction5
Strategies to Promote Vaccine Uptake in the COVID-19 Pandemic: Exploring the “Ladder of Intrusiveness” in Three Countries5
The Political Determinants of Health and the European Union5
Medicaid Waivers to Address Homelessness: Political Development and Policy Trajectories5
The Political Economy of Market Power in Pharmaceuticals5
It’s Only a Crisis if It’s Fit to Print: Examining the Relationship Between Overdose Rates, News Coverage, and the Presence of the Opioid Crisis in State Legislative Campaigns5
Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices5
Criminal Records and Licensure in Five Allied Health Professions: Is There Evidence of a Disparate Impact on Historically Marginalized Groups?5
Potemkin Protections: Assessing Provider Directory Accuracy and Timely Access for Four Specialties in California5
Is Redistribution Good for Our Health? Examining the Macrocorrelation between Welfare Generosity and Health across EU Nations over the Last 40 Years5
Entrenched Opportunity: Medicaid, Health Systems, and Solutions to Homelessness4
Medicare at 60: A Popular Program Facing Challenges4
The Changing Politics of Guns in America4
Self-Sourced Medication Abortion, Physician Authority, and the Contradictions of Abortion Care4
Incentivizing COVID-19 Vaccination in a Polarized and Partisan United States4
More Than Words? How Highlighting Target Populations Affects Public Opinion about the Medicaid Program4
Partisanship and the Pandemic: How and Why Americans Followed Party Cues on COVID-194
Administering a Chill Pill? Better Regulation and the Potential for Regulatory Chill in European Union Health Policy4
Lots of Pain for Little Gain: Three Decades of Medicaid Estate Recovery4
Intellectual Property and the Politics of Public Good during COVID-19: Framing Law, Institutions, and Ideas during TRIPS Waiver Negotiations at the WTO4
0.77955198287964